Psychopharmacology Case Studies: GAD and Depression
This paper presents three psychopharmacology case studies exploring the etiology, diagnosis, and treatment of generalized anxiety disorder (GAD) and depression across different patient populations. The first case examines GAD in an adolescent presenting with chronic worry, insomnia, and irritability, with treatment options including cognitive behavioral therapy and antidepressants. The second case addresses a child exhibiting symptoms consistent with both depression and hypothyroidism, highlighting the role of family, school, and environmental factors in diagnosis and treatment. The third case focuses on a 48-year-old woman experiencing depression following spousal bereavement, with discussion of vascular depression, DSM-5 diagnostic criteria, and complementary treatment approaches including psychotherapy and alternative medicine.
- Case 1: Generalized Anxiety Disorder (GAD): GAD etiology and symptoms in an anxious adolescent
- Diagnosis of GAD: DSM-5 criteria and clinical evaluation for GAD
- Treatment and Management of GAD: CBT, antidepressants, and lifestyle strategies for GAD
- Case 2: Depression and Hypothyroidism in a Child: Depression and hypothyroidism as differential diagnoses in a child
- Diagnosis and Treatment of Childhood Depression: Interviewing, questionnaires, Prozac, and psychotherapy for children
- Case 3: Depression in an Older Adult: Bereavement-triggered depression and vascular factors in a 48-year-old woman
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Applies a consistent three-part structure (etiology, diagnosis, treatment) across all three cases, making the analytical framework easy to follow.
- Integrates DSM-5 diagnostic criteria directly into clinical reasoning, demonstrating familiarity with standard psychiatric classification tools.
- Considers differential diagnoses, such as hypothyroidism alongside depression in Case 2, showing critical thinking beyond a single-label approach.
- Addresses patient-specific factors (age, life circumstances, family context) that shape both diagnosis and treatment selection.
Key academic technique demonstrated
The paper demonstrates applied clinical reasoning by moving systematically from possible etiologies to formal diagnostic criteria to individualized treatment recommendations. Each case uses published criteria (DSM-5) and named pharmacological agents with their brand equivalents, grounding the discussion in professional psychopharmacology practice rather than general description.
Structure breakdown
The paper is organized into three discrete case studies. Each case opens with possible etiologies, proceeds through formal diagnostic considerations, and concludes with management and treatment recommendations. This parallel structure across all three cases reinforces the clinical method and makes comparative reading straightforward. References follow APA format and draw from clinical handbooks and reputable health information sources.
Case 1: Generalized Anxiety Disorder (GAD)
Possible Etiology
Generalized anxiety disorder (GAD) is a widespread anxiety condition characterized by chronic worrying, tension, and nervousness. This is distinct from a phobia, which involves fear of something specific or a particular situation. GAD diffuses a feeling of dread and unease across all aspects of a person's life. The anxiety is not as intense as a panic attack but lasts much longer, consequently lowering the general quality of life over an extended period. Regardless of whether a person is aware that their worrying is exaggerated, or believes that such worries protect them in some way, the consequence is the same: it is impossible to deliberately turn off the anxiety. Worries form an endless stream that flows through the mind (Segal, 2016). The first patient in this case study presents as a possible GAD case, as his worrying is now significantly affecting his quality of life, with anxiety and lack of sleep leading to mood swings and irritability.
Diagnosis of GAD
In order to assist the patient in dealing with generalized anxiety disorder, the health expert may conduct a physical examination to establish whether there is an underlying condition connected to the anxiety; request urine and blood tests if a medical condition is suspected; ask the patient pointed questions about his medical history and symptoms; and employ psychological assessment tools to determine a diagnosis.
Many experts apply the criteria laid out in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published by the American Psychiatric Association, to investigate mental health conditions. The manual is also used by insurance companies in their compensation analysis processes.
The DSM-5 criteria for GAD include: exaggerated anxiety experienced on most days of the week about numerous events for a period spanning six months or longer; difficulty controlling the worry; and the presence of at least three of the following symptoms in adults — fatigue, restlessness, irritability, muscle tension, sleep problems, and concentration difficulties. The patient already presents with anxiety, sleep issues, and irritability. The following will therefore be examined in his case: whether his anxiety causes him significant distress and negatively disrupts his daily life; and whether his anxiety has no apparent link to a medical condition such as post-traumatic stress disorder, a physical illness, or substance abuse.
Treatment and Management of GAD
Psychotherapy
There are two primary treatment approaches for GAD: medications and psychotherapy. Research has shown that a combination of both treatments produces better results. However, it may be a process of trial and error to determine the most effective treatment plan for the patient.
Psychotherapy, also commonly referred to as talk therapy, involves working with a psychotherapist to reduce the symptoms of anxiety. It is frequently effective for GAD. Cognitive behavioral therapy (CBT) is considered the most effective psychotherapeutic treatment for GAD. The therapy aims to gradually guide the patient back toward activities that have triggered anxiety, helping him confront and manage them. The process involves gradual improvement that builds upon earlier successes.
Medications
Several medications are used in the treatment of GAD. It is essential that the patient consults with his healthcare providers to settle on the most appropriate medications for his condition, ensuring due consideration is given to potential side effects and overall effectiveness. First-choice medications for the treatment of GAD include antidepressants such as serotonin-norepinephrine reuptake inhibitors (SNRIs) and selective serotonin reuptake inhibitors (SSRIs). Specific antidepressants include venlafaxine (Effexor XR), paroxetine (Paxil, Pexeva), duloxetine (Cymbalta), and escitalopram (Lexapro). There is a chance that the health provider may propose alternative antidepressants. In that case, the patient is advised to avoid all sedatives including alcohol, reduce coffee intake, and embrace various relaxation techniques such as yoga or meditation. He should also maintain a healthy diet rich in fruits, fish, whole grains, and vegetables. These measures may be linked to stress and anxiety reduction, though more research is needed to confirm their efficacy (Mayo Clinic, 2014).
In summary, the patient has manifested possible symptoms of GAD. He feels anxious and experiences sleeping problems that are disrupting his normal daily functioning, including routine and behavioral changes. He is a potential case for GAD and is therefore suitable for a formal GAD examination.
Create your account
Always verify citation format against your institution’s current style guide requirements.